AVRT

CORRECTING AND REPLACING: StageZero Life Sciences Announces Availability of COC Protocol in Europe

Retrieved on: 
Monday, March 14, 2022

This builds on the availability of the service and program in the UK, the US and Canada.

Key Points: 
  • This builds on the availability of the service and program in the UK, the US and Canada.
  • The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage.
  • Developed by scientists and oncologists, the COC Protocol is intended for adjunctive administration alongside standard-of-care cancer therapy.
  • StageZero Life Sciences trades on the Toronto Stock exchange under the symbol SZLS and on the OTCQB under the symbol SZLSF.

StageZero Life Sciences Announces Availability of COC Protocol in Europe

Retrieved on: 
Monday, March 14, 2022

This builds on the availability of the service and program in the UK, the US and Canada.

Key Points: 
  • This builds on the availability of the service and program in the UK, the US and Canada.
  • The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage.
  • Developed by scientists and oncologists, the COC Protocol is intended for adjunctive administration alongside standard-of-care cancer therapy.
  • StageZero Life Sciences trades on the Toronto Stock exchange under the symbol SZLS and on the OTCQB under the symbol SZLSF.

International Journal of Cardiology Publishes Data Demonstrating Superior Outcomes of Stereotaxis Robotic Cardiac Ablation in Pediatric Patients

Retrieved on: 
Tuesday, October 12, 2021

The 223-patient study, conducted at Erasmus Medical Center in Rotterdam, the Netherlands, compared Robotic Magnetic Navigation (RMN) guided cardiac ablation to manual radiofrequency (RF) ablation and manual cryoablation.

Key Points: 
  • The 223-patient study, conducted at Erasmus Medical Center in Rotterdam, the Netherlands, compared Robotic Magnetic Navigation (RMN) guided cardiac ablation to manual radiofrequency (RF) ablation and manual cryoablation.
  • We are excited to share data from this large long-term comparative study, said Dr. Anne-Marie Noten, author of the publication.
  • It builds upon the significant body of evidence supporting the clinical value of robotics for arrhythmia patients, particularly the most vulnerable patients with complex disease.
  • Although cardiac ablation is a common treatment for AV(N)RT, there is risk of procedural complications, and the impact of procedural radiation on pediatric patients is a concern.